Immunotherapy of HPV 16-associated tumours with tumour cell line/dendritic cell line (TC-1/DC2.4) hybrid vaccines

Folia Biologica

Volumn 49, Issue 5, 2003, Pages 203-206

  Šímová, Jana ^a   Bieblova J ^a   Jandlova T ^a   Bubenik J ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

Dendritic cells; Fusion; HPV16

Indexed keywords

AMINOPTERIN; CANCER VACCINE; HYPOXANTHINE; THYMIDINE;

ARTICLE; CANCER GRAFT; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL FUSION; CELL HYBRIDIZATION; CELL LINE; CELL POPULATION; CULTURE MEDIUM; DENDRITIC CELL; DRUG POTENCY; HYBRID CELL; MALE; MOUSE; NONHUMAN; STATISTICAL SIGNIFICANCE; TUMOR CELL LINE; TUMOR VOLUME; WART VIRUS;

HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0344685198     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bubeník, J. (2001) Genetically engineered dendritic cellbased cancer vaccines. Int. J Oncol. 18, 475-478.
2. Celluzzi, C. M., Falo, D. Jr. (1998) Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection. J. Immunol. 160, 3081-3085.
3. Chen, D., Xia, J., Tanaka, Y., Chen, H., Koido, S., Wernet, O., Mukherjee, P., Gendler, S. J., Kufe, D., Gong, J. (2003) Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells. Immunology 109, 300-307.
4. Coventry, B. J., Morton, J. (2003 ) CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer. Br. J Cancer 89, 533-538.
5. Dallal, R. M., Christakos, P., Lee, K., Egawa, S., Son, Y.-I., Lotze, M. T. (2002) Paucity of dendritic cells in pancreatic cancer. Surgery 131, 135-138.
6. Gong, J., Chen, D., Kashiwaba, M., Kufe, D. (1997) Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat. Med. 3, 558-561.
7. Ishigami, S., Natsugoe, S., Tokuda, K., Nakajo, A., Xiangming, C., Iwashige, H., Aridome, K., Hokita, S., Aikou, T. (2000) Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer. Cancer Lett. 159, 103-108.
8. Kikuchi, T., Akasaki, Y., Irie, I., Homma, S., Abe, T., Ohno, T. (2001) Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol. Immunother 50, 337-344.
9. Kugler, A., Stuhler, G., Walden, P., Zoller, P., Zobywalski, A., Brossart, P., Trefzer, U., Ullrich, S., Müller, C. A., Becker, V., Gross, A. J., Hemmerlein, B., Kanz, L., Müller, G. A., Ringert, R.-H. (2000) Regression of human metastatic renal cell carcinoma atter vaccination with tumor cell-dendritic cell hybrids. Nat. Med. 6, 332-336.
10. Lin, K. Y., Guarnieri, F. G., Staveley, O. K., Levitsky, H. I., August, J. T., Pardoll, D. M., Wu, T. C. (1996) Treatment of established tumours with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56, 21-26.
11. Mendoza, L., Bubeník, J., Šímová, J., Korb, J., Bieblovǎ, J., Vonka, V, Indrová, M., Mikyškovǎ, R., Jandlovǎ, T. (2002) Tumour-inhibitory effects of dendritic cells administered at the site of HPV 16-induced neoplasms. Folia Biol. (Praha) 48, 114-119.
12. Mendoza, L., Bubeník, J., Šímová, J., Jandlová, T., Vonka, V., Mikyšková,. R. (2003) Prophylactic, therapeutic and antimetastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours. Int. J. Oncol. 23, 243-247.
13. Oretas, R. J., Schauer, D., Bin, Q., Johnson, B. D. (2001) Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumour vaccine. Cell. Immunol. 213, 4-13.
14. Reinhard, G., Märted, A., Kiske, S. M. Feil, F., SchmidtWolf, I. G. H. (2002) Generation of dendritic cell-based vaccines for cancer therapy. Br J. Cancer 86, 1529-1533.
15. Shen, Z., Reznikoff, G., Dranoff, G., Rock, K. L. (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158, 2723-2730.
16. Steinman, R. M. (1991) The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271-276.
17. Tsujitani, S., Kakeji, Y., Watanabe, A., Kohnoe, S., Maehara, Y., Sugimaghi, K. (1992) Infiltration of S-100 protein positive dendritic cells and peritoneal recurrence in advanced gastric cancer. Int. Surg. 77, 238-241.
18. Trefzer, U., Weingart, G., Chen, Y., Herberth, G., Adrian, K., Winter, H., Audring, H., Guo, Z., Sterry, W., Walden, P. (2000) Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma. Int. J. Cancer 85, 618-626.
19. Wang, J., Saffold, S., Cao, X., Krauss, J., Chen W. (1998) Eliciting T cell immunity against poorly immunogenic tumours by immunization with dendritic cell-tumor fusion vaccines. J. Immunol. 161, 5516-5526.